

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.57350019 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.57350019 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.57350019 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.57350019 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.57350019 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.57350019 |
| 7 | response to peptidoglycan (GO:0032494) | 5.26399216 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87380305 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.82277541 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.77859166 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.46733893 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.41746559 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.39852587 |
| 14 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.36479644 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.34859112 |
| 16 | response to host immune response (GO:0052572) | 4.34859112 |
| 17 | detection of other organism (GO:0098543) | 4.32924137 |
| 18 | response to muramyl dipeptide (GO:0032495) | 4.32541145 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.30549312 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.27373711 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.27373711 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.14136815 |
| 23 | detection of bacterium (GO:0016045) | 4.13584894 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.05045383 |
| 25 | respiratory burst (GO:0045730) | 4.03924204 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 3.97898451 |
| 27 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.97425861 |
| 28 | response to host (GO:0075136) | 3.97213688 |
| 29 | response to host defenses (GO:0052200) | 3.97213688 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.97213688 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.92295906 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88219822 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.87525272 |
| 34 | granulocyte activation (GO:0036230) | 3.80609641 |
| 35 | leukocyte aggregation (GO:0070486) | 3.76122258 |
| 36 | positive regulation of heat generation (GO:0031652) | 3.71398456 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.69879462 |
| 38 | microglial cell activation (GO:0001774) | 3.68638998 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.66897806 |
| 40 | neutrophil activation (GO:0042119) | 3.65062600 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60666508 |
| 42 | regulation of chemokine biosynthetic process (GO:0045073) | 3.59417639 |
| 43 | type I interferon signaling pathway (GO:0060337) | 3.58958381 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.58958381 |
| 45 | response to type I interferon (GO:0034340) | 3.56734225 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.56061893 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53681362 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.53681362 |
| 49 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.53546614 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52078644 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.48890576 |
| 52 | regulation of fever generation (GO:0031620) | 3.48306161 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.46745092 |
| 54 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.43849556 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.42817169 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.41769692 |
| 57 | positive regulation of interferon-beta production (GO:0032728) | 3.36480664 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.34314102 |
| 59 | macrophage activation (GO:0042116) | 3.33435282 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.33009824 |
| 61 | detection of biotic stimulus (GO:0009595) | 3.32650616 |
| 62 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.25891558 |
| 63 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.25695161 |
| 64 | T cell migration (GO:0072678) | 3.24785243 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24330927 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23154292 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.22411903 |
| 68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.21336409 |
| 69 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.19976213 |
| 70 | natural killer cell mediated immunity (GO:0002228) | 3.19976213 |
| 71 | detection of molecule of bacterial origin (GO:0032490) | 3.17580848 |
| 72 | reactive oxygen species biosynthetic process (GO:1903409) | 3.17513856 |
| 73 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.17160858 |
| 74 | regulation of gamma-delta T cell activation (GO:0046643) | 3.15533518 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 3.14788127 |
| 76 | myeloid dendritic cell differentiation (GO:0043011) | 3.13113809 |
| 77 | defense response to protozoan (GO:0042832) | 3.09108422 |
| 78 | B cell mediated immunity (GO:0019724) | 3.08839953 |
| 79 | regulation of chronic inflammatory response (GO:0002676) | 3.08685609 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08219193 |
| 81 | low-density lipoprotein particle clearance (GO:0034383) | 3.07410948 |
| 82 | I-kappaB phosphorylation (GO:0007252) | 3.07250642 |
| 83 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05796790 |
| 84 | regulation of podosome assembly (GO:0071801) | 3.04280461 |
| 85 | T-helper 1 type immune response (GO:0042088) | 3.04094254 |
| 86 | positive regulation of humoral immune response (GO:0002922) | 3.02920485 |
| 87 | superoxide anion generation (GO:0042554) | 3.02662386 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02261145 |
| 89 | leukocyte cell-cell adhesion (GO:0007159) | 3.00596726 |
| 90 | response to interleukin-15 (GO:0070672) | 2.99908793 |
| 91 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.99541714 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 2.98027704 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97700513 |
| 94 | regulation of mast cell activation (GO:0033003) | 2.97468176 |
| 95 | germinal center formation (GO:0002467) | 2.96854329 |
| 96 | neutrophil mediated immunity (GO:0002446) | 2.96310964 |
| 97 | regulation of mononuclear cell migration (GO:0071675) | 2.95774431 |
| 98 | positive regulation of type 2 immune response (GO:0002830) | 2.93828408 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 2.93626641 |
| 100 | positive regulation of mast cell activation (GO:0033005) | 2.92246527 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 2.91821780 |
| 102 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.91617097 |
| 103 | positive regulation of tolerance induction (GO:0002645) | 2.91448714 |
| 104 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90969931 |
| 105 | positive regulation of interleukin-12 production (GO:0032735) | 2.89929924 |
| 106 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.89097419 |
| 107 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.89097419 |
| 108 | negative regulation of interleukin-17 production (GO:0032700) | 2.88821398 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86152742 |
| 110 | positive regulation of mast cell degranulation (GO:0043306) | 2.86019951 |
| 111 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86019951 |
| 112 | cellular extravasation (GO:0045123) | 2.85942333 |
| 113 | lymphocyte chemotaxis (GO:0048247) | 2.85857436 |
| 114 | tolerance induction (GO:0002507) | 2.85551876 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.84756305 |
| 116 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.84456921 |
| 117 | regulation of interleukin-12 production (GO:0032655) | 2.83837520 |
| 118 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83240062 |
| 119 | negative regulation of viral genome replication (GO:0045071) | 2.81249505 |
| 120 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81153933 |
| 121 | leukocyte mediated cytotoxicity (GO:0001909) | 2.81137363 |
| 122 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.80039029 |
| 123 | myeloid leukocyte activation (GO:0002274) | 2.79896548 |
| 124 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.79692713 |
| 125 | positive regulation of chemokine production (GO:0032722) | 2.79371614 |
| 126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79114391 |
| 127 | response to protozoan (GO:0001562) | 2.78549702 |
| 128 | positive regulation of B cell differentiation (GO:0045579) | 2.78506302 |
| 129 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77522526 |
| 130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.77151367 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76922342 |
| 132 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76085654 |
| 133 | negative regulation of interleukin-6 production (GO:0032715) | 2.75936824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.40538608 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.30065596 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.75446501 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.26179985 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.18304492 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.03532649 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.02890041 |
| 8 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82660192 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.70650476 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.64265812 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40272129 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28880384 |
| 13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.28507407 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.12419016 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03586143 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.95759502 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93547387 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70310314 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58147753 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40432919 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.40117511 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25168430 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08739666 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.05390882 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90384642 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 1.89936610 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.89750247 |
| 28 | * MAF_26560356_Chip-Seq_TH1_Human | 1.87324020 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86441064 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78578722 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77908237 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77238353 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73670856 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72998970 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72142814 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70030186 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.68109355 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65325738 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62719594 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62495868 |
| 41 | * MYB_26560356_Chip-Seq_TH1_Human | 1.60407052 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56741923 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54111789 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53144709 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48415903 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44687866 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43706386 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37603181 |
| 49 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.37195482 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37104219 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32440200 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31956035 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31669322 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29197915 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28954157 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.25385133 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24788025 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24193097 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22152429 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21404442 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21191641 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18343005 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17588031 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16239903 |
| 65 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16155495 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14329472 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12195955 |
| 68 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11634527 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10321707 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09349185 |
| 71 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09297274 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.09038472 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07511640 |
| 74 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06723110 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06202528 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04621399 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04289730 |
| 78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04027779 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98846468 |
| 80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96371022 |
| 81 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.96236293 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96222881 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91580376 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91157477 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90989214 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89546941 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88506945 |
| 88 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.87059187 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85661919 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84833914 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84524061 |
| 92 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82512618 |
| 93 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80409093 |
| 94 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.80014181 |
| 95 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79559463 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79396890 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78368290 |
| 98 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78207999 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78004835 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77778253 |
| 101 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77320143 |
| 102 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76027672 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74476581 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74155953 |
| 105 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72297160 |
| 106 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71301137 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71218294 |
| 108 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.70005824 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.68872966 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.68872966 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67973186 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67674716 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67642736 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66533666 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64777151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.93675272 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.88795455 |
| 3 | MP0009785_altered_susceptibility_to | 3.74273928 |
| 4 | MP0003436_decreased_susceptibility_to | 3.64859147 |
| 5 | MP0006082_CNS_inflammation | 3.21600827 |
| 6 | MP0002419_abnormal_innate_immunity | 3.12140859 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.03614436 |
| 8 | MP0003724_increased_susceptibility_to | 2.99734392 |
| 9 | MP0004510_myositis | 2.97505829 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.96401485 |
| 11 | MP0000685_abnormal_immune_system | 2.85379874 |
| 12 | * MP0005025_abnormal_response_to | 2.81908607 |
| 13 | * MP0005387_immune_system_phenotype | 2.78559525 |
| 14 | * MP0001790_abnormal_immune_system | 2.78559525 |
| 15 | MP0005671_abnormal_response_to | 2.73186412 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.69929620 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.64778862 |
| 18 | MP0001800_abnormal_humoral_immune | 2.63083897 |
| 19 | * MP0002723_abnormal_immune_serum | 2.51706317 |
| 20 | MP0004947_skin_inflammation | 2.36012939 |
| 21 | * MP0001819_abnormal_immune_cell | 2.25402652 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.22973084 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.16523214 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.10357536 |
| 25 | MP0009278_abnormal_bone_marrow | 2.09056913 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.07309945 |
| 27 | * MP0001845_abnormal_inflammatory_respons | 1.90483496 |
| 28 | * MP0002405_respiratory_system_inflammati | 1.88969244 |
| 29 | MP0009840_abnormal_foam_cell | 1.88915076 |
| 30 | MP0003448_altered_tumor_morphology | 1.86155855 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.77433585 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.77087657 |
| 33 | MP0001853_heart_inflammation | 1.74024759 |
| 34 | * MP0008469_abnormal_protein_level | 1.70861046 |
| 35 | MP0000604_amyloidosis | 1.70101848 |
| 36 | MP0000343_altered_response_to | 1.69724298 |
| 37 | MP0005451_abnormal_body_composition | 1.69465983 |
| 38 | MP0009764_decreased_sensitivity_to | 1.67948439 |
| 39 | MP0003075_altered_response_to | 1.67669731 |
| 40 | * MP0000716_abnormal_immune_system | 1.65206831 |
| 41 | MP0002006_tumorigenesis | 1.65096158 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.62364583 |
| 43 | * MP0002398_abnormal_bone_marrow | 1.57589787 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.54636772 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.52165315 |
| 46 | MP0005310_abnormal_salivary_gland | 1.48948347 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.46978544 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.46978544 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.42911146 |
| 50 | MP0000858_altered_metastatic_potential | 1.40737159 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.40363673 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.39296963 |
| 53 | MP0002254_reproductive_system_inflammat | 1.35528079 |
| 54 | * MP0002429_abnormal_blood_cell | 1.31886743 |
| 55 | MP0008004_abnormal_stomach_pH | 1.29388670 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.27986019 |
| 57 | MP0002722_abnormal_immune_system | 1.27745481 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.27567489 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.27106322 |
| 60 | MP0005166_decreased_susceptibility_to | 1.25764515 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.23487619 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.19028757 |
| 63 | MP0002933_joint_inflammation | 1.16317170 |
| 64 | MP0010307_abnormal_tumor_latency | 1.14565102 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.10941445 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.08271207 |
| 67 | MP0004883_abnormal_blood_vessel | 1.04403947 |
| 68 | MP0001851_eye_inflammation | 1.04390313 |
| 69 | MP0001873_stomach_inflammation | 1.03460893 |
| 70 | MP0009763_increased_sensitivity_to | 1.02279995 |
| 71 | MP0005390_skeleton_phenotype | 1.00475979 |
| 72 | MP0005164_abnormal_response_to | 1.00324882 |
| 73 | MP0002132_abnormal_respiratory_system | 0.99387911 |
| 74 | MP0002139_abnormal_hepatobiliary_system | 0.97223997 |
| 75 | MP0001663_abnormal_digestive_system | 0.96585132 |
| 76 | MP0003828_pulmonary_edema | 0.94835041 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.93984323 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.93308975 |
| 79 | MP0006054_spinal_hemorrhage | 0.93071179 |
| 80 | MP0003690_abnormal_glial_cell | 0.91432496 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.91173508 |
| 82 | MP0005083_abnormal_biliary_tract | 0.88044834 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.87467318 |
| 84 | MP0003091_abnormal_cell_migration | 0.87406119 |
| 85 | MP0000249_abnormal_blood_vessel | 0.85634977 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.83273579 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.80891088 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.80768174 |
| 89 | MP0005023_abnormal_wound_healing | 0.78577974 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.76916562 |
| 91 | MP0003186_abnormal_redox_activity | 0.76555883 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.76250223 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.74905721 |
| 94 | MP0000371_diluted_coat_color | 0.72490408 |
| 95 | MP0003795_abnormal_bone_structure | 0.71408922 |
| 96 | MP0000609_abnormal_liver_physiology | 0.70090059 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.69368685 |
| 98 | MP0008260_abnormal_autophagy | 0.68955466 |
| 99 | MP0004381_abnormal_hair_follicle | 0.67829933 |
| 100 | MP0003195_calcinosis | 0.67587769 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.67267479 |
| 102 | MP0003045_fibrosis | 0.66757184 |
| 103 | MP0000920_abnormal_myelination | 0.66562486 |
| 104 | MP0008874_decreased_physiological_sensi | 0.66206668 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.63653611 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.62425775 |
| 107 | MP0000490_abnormal_crypts_of | 0.60525819 |
| 108 | MP0001958_emphysema | 0.60182483 |
| 109 | MP0003866_abnormal_defecation | 0.58916034 |
| 110 | MP0003329_amyloid_beta_deposits | 0.58020862 |
| 111 | MP0008873_increased_physiological_sensi | 0.57868117 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.56205386 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.55068107 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.54341868 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.53869504 |
| 116 | MP0001542_abnormal_bone_strength | 0.53839902 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53355539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.82084024 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.55139286 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.10993915 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.55484276 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.11371769 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.99792275 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.94437945 |
| 8 | Stomatitis (HP:0010280) | 4.83413949 |
| 9 | Orchitis (HP:0100796) | 4.82808389 |
| 10 | Myositis (HP:0100614) | 4.75103855 |
| 11 | Optic neuritis (HP:0100653) | 4.71446535 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.71446535 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.32516541 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 4.07290472 |
| 15 | Gingivitis (HP:0000230) | 3.85090585 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.83997535 |
| 17 | Recurrent skin infections (HP:0001581) | 3.81922741 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.76975436 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.76219674 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.70529199 |
| 21 | Obstructive lung disease (HP:0006536) | 3.65650640 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.65650640 |
| 23 | Vasculitis (HP:0002633) | 3.62328478 |
| 24 | Recurrent viral infections (HP:0004429) | 3.37155438 |
| 25 | Encephalitis (HP:0002383) | 3.29495527 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.28949984 |
| 27 | Chronic otitis media (HP:0000389) | 3.23865754 |
| 28 | Pustule (HP:0200039) | 3.12947350 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05101272 |
| 30 | Increased IgM level (HP:0003496) | 2.98355036 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97459164 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97459164 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97459164 |
| 34 | Arterial thrombosis (HP:0004420) | 2.93946211 |
| 35 | Periodontitis (HP:0000704) | 2.92815964 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 2.89641604 |
| 37 | Myocardial infarction (HP:0001658) | 2.88492223 |
| 38 | Tetraparesis (HP:0002273) | 2.87070712 |
| 39 | Axonal loss (HP:0003447) | 2.86824453 |
| 40 | Leukocytosis (HP:0001974) | 2.86749274 |
| 41 | Urticaria (HP:0001025) | 2.84160034 |
| 42 | Hematochezia (HP:0002573) | 2.81497489 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.79527227 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.75507813 |
| 45 | Nasal polyposis (HP:0100582) | 2.75459293 |
| 46 | Cellulitis (HP:0100658) | 2.73725970 |
| 47 | Prostate neoplasm (HP:0100787) | 2.73517690 |
| 48 | Thick nail (HP:0001805) | 2.72602611 |
| 49 | Meningitis (HP:0001287) | 2.72527106 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.71554048 |
| 51 | Disinhibition (HP:0000734) | 2.69748625 |
| 52 | Glomerulonephritis (HP:0000099) | 2.68359013 |
| 53 | Episodic fever (HP:0001954) | 2.63871092 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.62450049 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.62015259 |
| 56 | Hemoptysis (HP:0002105) | 2.56843462 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53922027 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53922027 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.51445165 |
| 60 | Purpura (HP:0000979) | 2.49881439 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48275311 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.47231797 |
| 63 | Gingival bleeding (HP:0000225) | 2.45099663 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.44130788 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44130788 |
| 66 | Loss of speech (HP:0002371) | 2.41347340 |
| 67 | Osteomyelitis (HP:0002754) | 2.40292691 |
| 68 | Mutism (HP:0002300) | 2.37005621 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31965839 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31965839 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31965839 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.30641179 |
| 73 | Abnormality of T cells (HP:0002843) | 2.28771519 |
| 74 | Polyneuropathy (HP:0001271) | 2.28193551 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27339172 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.26753180 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.26690254 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.26517901 |
| 79 | Peritonitis (HP:0002586) | 2.25778838 |
| 80 | Amyloidosis (HP:0011034) | 2.24342055 |
| 81 | Anorexia (HP:0002039) | 2.20198501 |
| 82 | Vertebral compression fractures (HP:0002953) | 2.20186111 |
| 83 | Abnormality of T cell number (HP:0011839) | 2.20156260 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.19457147 |
| 85 | Lymphopenia (HP:0001888) | 2.18589025 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15850580 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 2.15850580 |
| 88 | Recurrent pneumonia (HP:0006532) | 2.14800232 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.14459238 |
| 90 | Joint swelling (HP:0001386) | 2.14322773 |
| 91 | Eosinophilia (HP:0001880) | 2.14289731 |
| 92 | Recurrent bronchitis (HP:0002837) | 2.13809986 |
| 93 | Granulocytopenia (HP:0001913) | 2.13180572 |
| 94 | Vertigo (HP:0002321) | 2.09250329 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 2.08793637 |
| 96 | Glomerulopathy (HP:0100820) | 2.07338791 |
| 97 | Colitis (HP:0002583) | 2.06966207 |
| 98 | Abnormality of the pericardium (HP:0001697) | 2.04430475 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.04190182 |
| 100 | Increased IgE level (HP:0003212) | 2.03841698 |
| 101 | Malnutrition (HP:0004395) | 2.03639427 |
| 102 | Bone pain (HP:0002653) | 2.03444584 |
| 103 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02535970 |
| 104 | Pulmonary embolism (HP:0002204) | 2.02008820 |
| 105 | Nephritis (HP:0000123) | 2.01421737 |
| 106 | Acne (HP:0001061) | 2.01174341 |
| 107 | Increased serum ferritin (HP:0003281) | 2.01059154 |
| 108 | T lymphocytopenia (HP:0005403) | 2.00290384 |
| 109 | Sepsis (HP:0100806) | 1.99709329 |
| 110 | Abnormality of the endocardium (HP:0004306) | 1.99616144 |
| 111 | Abnormality of the prostate (HP:0008775) | 1.99209821 |
| 112 | Arthralgia (HP:0002829) | 1.98024950 |
| 113 | Panhypogammaglobulinemia (HP:0003139) | 1.97607614 |
| 114 | Inflammation of the large intestine (HP:0002037) | 1.96991598 |
| 115 | Petechiae (HP:0000967) | 1.96961931 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 1.96712222 |
| 117 | Restrictive lung disease (HP:0002091) | 1.95992182 |
| 118 | Chest pain (HP:0100749) | 1.95282095 |
| 119 | Epistaxis (HP:0000421) | 1.94542035 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.94110265 |
| 121 | Gangrene (HP:0100758) | 1.94048076 |
| 122 | Emphysema (HP:0002097) | 1.93081181 |
| 123 | Frequent falls (HP:0002359) | 1.92420920 |
| 124 | Joint hemorrhage (HP:0005261) | 1.91645311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.50759277 |
| 2 | TBK1 | 3.87505814 |
| 3 | RIPK4 | 3.65747201 |
| 4 | TYK2 | 3.51417308 |
| 5 | IRAK3 | 3.33188016 |
| 6 | MAP4K1 | 3.13838460 |
| 7 | IKBKE | 3.07634630 |
| 8 | IRAK4 | 3.00788591 |
| 9 | BLK | 2.96244653 |
| 10 | TXK | 2.84427511 |
| 11 | PRPF4B | 2.65508998 |
| 12 | IKBKB | 2.58911638 |
| 13 | JAK3 | 2.57743998 |
| 14 | JAK1 | 2.31925045 |
| 15 | KIT | 2.24948082 |
| 16 | ERN1 | 2.08364675 |
| 17 | TAOK1 | 2.04878099 |
| 18 | MAP3K13 | 1.97307379 |
| 19 | CSK | 1.90985523 |
| 20 | TAOK2 | 1.80084420 |
| 21 | EPHB1 | 1.73147362 |
| 22 | CHUK | 1.72016176 |
| 23 | ZAP70 | 1.69155222 |
| 24 | TNK2 | 1.64858045 |
| 25 | HCK | 1.38859129 |
| 26 | CSF1R | 1.36873174 |
| 27 | RPS6KA4 | 1.35149921 |
| 28 | STK10 | 1.34432230 |
| 29 | FGFR4 | 1.34413241 |
| 30 | TAOK3 | 1.33802606 |
| 31 | FGR | 1.32429487 |
| 32 | MAP3K10 | 1.30996048 |
| 33 | PBK | 1.30713063 |
| 34 | SYK | 1.30418748 |
| 35 | TGFBR2 | 1.30036220 |
| 36 | LCK | 1.27499377 |
| 37 | JAK2 | 1.26437753 |
| 38 | PIM2 | 1.19566165 |
| 39 | MARK3 | 1.14185485 |
| 40 | FES | 1.11240125 |
| 41 | BTK | 1.08709430 |
| 42 | CDC42BPA | 1.06632683 |
| 43 | LYN | 1.05894865 |
| 44 | PIM1 | 1.03710786 |
| 45 | ITK | 0.98655611 |
| 46 | FGFR3 | 0.98399629 |
| 47 | MATK | 0.98257334 |
| 48 | MAP2K3 | 0.96926027 |
| 49 | BMX | 0.94669752 |
| 50 | PTK6 | 0.89339710 |
| 51 | MAP3K11 | 0.86719573 |
| 52 | NEK9 | 0.85585886 |
| 53 | TEC | 0.84639816 |
| 54 | DDR2 | 0.83860927 |
| 55 | TRIB3 | 0.81984730 |
| 56 | EPHA3 | 0.80814071 |
| 57 | NME2 | 0.80479476 |
| 58 | SIK2 | 0.80300313 |
| 59 | TESK2 | 0.75249905 |
| 60 | MARK2 | 0.71949048 |
| 61 | GRK6 | 0.71812704 |
| 62 | EGFR | 0.69616553 |
| 63 | TTN | 0.68344725 |
| 64 | MAP3K3 | 0.65876278 |
| 65 | CLK1 | 0.65585147 |
| 66 | ABL2 | 0.65071636 |
| 67 | RIPK1 | 0.64431249 |
| 68 | SIK3 | 0.64282218 |
| 69 | IRAK1 | 0.63731727 |
| 70 | LRRK2 | 0.63024306 |
| 71 | ABL1 | 0.61792809 |
| 72 | MAPK7 | 0.60089239 |
| 73 | MAP3K5 | 0.58742929 |
| 74 | PRKCD | 0.58707230 |
| 75 | PRKD2 | 0.57016748 |
| 76 | BMPR2 | 0.56032958 |
| 77 | MST4 | 0.54290671 |
| 78 | MAPK12 | 0.53068233 |
| 79 | CAMKK2 | 0.52736191 |
| 80 | PKN2 | 0.51567211 |
| 81 | HIPK2 | 0.50126173 |
| 82 | EIF2AK2 | 0.49691218 |
| 83 | MAP3K1 | 0.47570657 |
| 84 | ACVR1B | 0.46543598 |
| 85 | CAMK1D | 0.46270770 |
| 86 | RPS6KC1 | 0.44906782 |
| 87 | RPS6KL1 | 0.44906782 |
| 88 | MAP2K6 | 0.44608077 |
| 89 | ALK | 0.43882793 |
| 90 | CDK12 | 0.42745176 |
| 91 | YES1 | 0.42740389 |
| 92 | PRKG2 | 0.42115818 |
| 93 | PRKCQ | 0.40530270 |
| 94 | KSR2 | 0.39398325 |
| 95 | MAPKAPK2 | 0.38784285 |
| 96 | DAPK2 | 0.38486199 |
| 97 | PAK4 | 0.38426544 |
| 98 | RPS6KA6 | 0.38072685 |
| 99 | FYN | 0.37971816 |
| 100 | MST1R | 0.37862971 |
| 101 | STK4 | 0.37422248 |
| 102 | NLK | 0.36410105 |
| 103 | TYRO3 | 0.36118447 |
| 104 | IRAK2 | 0.36017336 |
| 105 | DYRK1B | 0.35883744 |
| 106 | TRPM7 | 0.35578230 |
| 107 | SMG1 | 0.35302561 |
| 108 | GSK3A | 0.32625670 |
| 109 | ADRBK2 | 0.32221594 |
| 110 | CDK6 | 0.31736936 |
| 111 | PDGFRB | 0.31688327 |
| 112 | SIK1 | 0.31277434 |
| 113 | GRK7 | 0.31079542 |
| 114 | MAPK4 | 0.30844616 |
| 115 | MOS | 0.30493295 |
| 116 | PDK1 | 0.29967088 |
| 117 | CDK4 | 0.29688355 |
| 118 | MAP3K7 | 0.29594819 |
| 119 | FLT3 | 0.29565173 |
| 120 | INSR | 0.28753621 |
| 121 | CAMKK1 | 0.28442984 |
| 122 | PDPK1 | 0.28216565 |
| 123 | SGK3 | 0.28147494 |
| 124 | STK3 | 0.27931505 |
| 125 | MAP3K6 | 0.27877697 |
| 126 | TESK1 | 0.26610107 |
| 127 | IGF1R | 0.26557422 |
| 128 | MAP3K8 | 0.24200503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.58872776 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.08407331 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.82396281 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.78621064 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.74610267 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68767255 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.55430740 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.48799485 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.42913072 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.36325981 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34076928 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.29233429 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.25721411 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.10899114 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07860408 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.05116857 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.03421576 |
| 18 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.03006905 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.85386193 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.83187959 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81188012 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77167035 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73652970 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.70799586 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65709608 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60472274 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.58125572 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56243353 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54100680 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53120296 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.52489421 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51182819 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.45149496 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45092980 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44041395 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.37993481 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36280889 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.35633024 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32054984 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27815262 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26613443 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.17588745 |
| 43 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16710716 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.14164130 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13494044 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12242422 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07358102 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02394036 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98167053 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.97878527 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96419043 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94539132 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92699857 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82948151 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82866261 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78506773 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75695238 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74248846 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73306843 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71927423 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71221929 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70646745 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65912142 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.65911814 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62691474 |
| 66 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62632919 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61150789 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60186380 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60092291 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56979374 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.56677056 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53156891 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.52730103 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50267841 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.48511271 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47527283 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47349914 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47294205 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44200520 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41516482 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40507399 |
| 82 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39923763 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37645976 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32930325 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31520274 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31144304 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.30721064 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30492993 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29583883 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.27815875 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27510912 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26306289 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26207329 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26151893 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25079425 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24792695 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22630500 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22459353 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22310154 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20894167 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20558595 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19591704 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19090103 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19057946 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.17973615 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15845966 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.15379631 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14413857 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.13318109 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.12656888 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12491461 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.11724769 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.10849851 |

